source
- Biomanufacturers Redesign Processes to Blend Emergency Vaccine Readiness with Commercial FlexibilityManufacturers are overhauling their production methods to simultaneously improve rapid vaccine deployment for future health crises and maintain flexible, commercially viable manufacturing networks…
- NewLimit raises $682M to pursue new class of anti-aging drugsNewLimit, a biotech startup based in South San Francisco, announced it secured $682 million in funding. The round was led by venture firms including Kleiner Perkins, Founders Fund, Dimension Capit…